A decade of change in susceptibility patterns of Gram-negative blood culture isolates: A single center study

GERMS

Volumn 5, Issue 3, 2015, Pages 65-77

  Alagesan, Murali ^a   Gopalakrishnan, Ram ^b   Panchatcharam, Senthur Nambi ^b   Dorairajan, Sureshkumar ^b   Ananth, Thirunarayan Mandayam ^b   Venkatasubramanian, Ramasubramanian ^b  

^a PSG INSTITUTE OF MEDICAL SCIENCES AND RESEARCH   (India)

^b APOLLO HOSPITALS   (India)

Author keywords

Antibiotic resistance; Bacteremia; Enterobacteriaceae; Gram negative infection

Indexed keywords

AMIKACIN; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; DORIPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD CULTURE; DISK DIFFUSION; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; OBSERVATIONAL STUDY; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY;

EID: 84940762708     PISSN: None     EISSN: 22482997     Source Type: Journal    
DOI: 10.11599/germs.2015.1073     Document Type: Article

References (20)

1. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis 2004;50:59-69. [CrossRef] [PubMed]
2. Marra AR, Camargo LF, Pignatari AC, et al. Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol 2011;49:1866 -71. [CrossRef] [PubMed] [FullText]
3. Lee NY, Lee HC, Ko NY, et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 2007;28:713-9. [CrossRef] [PubMed]
4. Gupta A, Sharma S, Arora A, Gupta A. Changing trends of in vitro antimicrobial resistance patterns in blood isolates in a tertiary care hospital over a period of 4 years. Indian J Med Sci 2010;64:485-92. [CrossRef] [PubMed]
5. Chadhary M, Kumar S, Payasi A. Prevalence and antimicrobial sensitivity of ESBL producing Gram-negative bacteria from clinical settings in India from 2010 to 2012. Int J Med Med Sci 2013;46:1212-7.
6. Jain S, Khety Z. Changing antimicrobial resistance pattern of isolates from an ICU over a 2 year period. J Assoc Physicians India 2012;60:27-8,33. [PubMed]
7. Kumhar GD, Ramachandran VG, Gupta P. Bacteriological analysis of blood culture isolates from neonates in a tertiary care hospital in India. J Health Popul Nutr 2002;20:343-7. [PubMed]
8. Kaul S, Brahmadathan KN, Jagannati M, et al. One year trends in the gram-negative bacterial antibiotic susceptibility patterns in a medical intensive care unit in South India. Indian J Med Microbiol 2007;25:230-5. [PubMed]
9. Rajeevan S, Ahmad SM, Jasmin PT. Study of prevalence and antimicrobial susceptibility pattern in blood isolates from a tertiary care hospital in North Kerala, India. Int J Curr Microbiol App Sci 2014;3:655-62.
10. Chhina D, Gupta V. Bacteriological profile and antimicrobial susceptibility pattern of blood isolates from a tertiary care hospital in North India. Int J Pharm Res Biosci 2013;2:24-35.
11. Vanitha Rani N, Kannan G, Venkata Narendra M, et al. A retrospective study on blood stream infections and antibiotic susceptibility patterns in a tertiary care teaching hospital. Int J Pharm Pharm Sci 2012;4:543-8.
12. Gopalakrishnan R, Sureshkumar D. Changing trends in antimicrobial susceptibility and hospital acquired infections over an 8 year period in a tertiary care hospital in relation to introduction of an infection control programme. J Assoc Physicians India. 2010;58 Suppl:25-31. [PubMed]
13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; thirteenth to twenty third informational supplements. CLSI document M100-18. Wayne, PA: Clinical and Laboratory Standards Institute. 2003 -2013.
14. Nair PK, Vaz MD. Prevalence of carbapenem resistant Enterobacteriaceae from a tertiary care hospital in Mumbai, India. J Microbiol Infect Dis 2013;3:207-10. [CrossRef]
15. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infec Dis 2011;53:60-7. [CrossRef] [PubMed]
16. Mohamudha Parveen R, Harish BN, Parija SC. Emerging carbapenem resistance among nosocomial isolates of Klebsiella pneumoniae in South India. Int J Pharma Biosci 2010;1:1-11.
17. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10: 597-602. [CrossRef] [PubMed] [FullText]
18. Gupta E, Mohanty S, Sood S, Dhawan B, Das BK, Kapil A. Emerging resistance to carbapenems in a tertiary care hospital in north India. Indian J Med Res 2006;124:95-8. [PubMed]
19. Sinha N, Agarwal J, Srivastava S, Singh M. Analysis of carbapenem-resistant Acinetobacter from a tertiary care setting in North India. Indian J Med Microbiol 2013;31:60-3. [CrossRef] [PubMed]
20. Chennai Declaration Team. "Chennai Declaration": 5-year plan to tackle the challenge of anti-microbial resistance. Indian J Med Microbiol 2014;32:221-8. [CrossRef] [PubMed]